Drugs / dapivirine

Trials 37 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 120 trials
Phase 1 NCT05041699 Jun 2022 → Oct 2024 hemorrhagic disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1 NCT03467347 Jul 2018 → Aug 2019 International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1 NCT03393468 May → Dec 2018 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 1 NCT03234400 Dec 2017 → Oct 2018 HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1 NCT03239483 Oct 2017 → Sep 2018 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 1 NCT02855346 May → Aug 2017 International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1 NCT02808949 Feb 2015 → Mar 2018 HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1 NCT01952561 Nov 2013 → Mar 2014 International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1 NCT01924091 Sep 2013 → Sep 2014 International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1 NCT01731574 Dec 2012 → Oct 2013 HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1/25 trials
Phase 1/2 NCT00917891 Nov 2009 → Jan 2011 AIDS International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1/2 NCT00917904 Jul 2009 → Sep 2010 AIDS International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1/2 NCT00309205 Dec 2005 → ? HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1/2 NCT00303576 Oct 2005 → Jul 2006 HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1/2 NCT00304668 HIV infectious disease International Partnership for Microbicides, Inc. Withdrawn No outcome recorded
Phase 23 trials
Phase 2 NCT03074786 Nov 2017 → Dec 2018 HIV infectious disease International Partnership for Microbicides, Inc. Withdrawn No outcome recorded
Phase 2 NCT02028338 Jun 2014 → Jul 2016 HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 2 NCT02010593 Dec 2013 → Apr 2015 HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 38 trials
Phase 3 NCT06250504 Feb 2024 → Apr 2026 overdue HIV infectious disease Africa Health Research Institute Recruiting No outcome recorded
Phase 3 NCT04140266 Sep 2020 → Nov 2021 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 3 NCT03965923 Jan 2020 → May 2024 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 3 NCT02858037 Jul 2016 → Oct 2018 HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 3 NCT02862171 Jul 2016 → Jan 2019 International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 3 NCT01617096 Jul 2012 → Jul 2015 HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 3 NCT01337583 Jul 2011 → Jul 2014 HIV infectious disease International Partnership for Microbicides, Inc. Withdrawn No outcome recorded
Phase 3 NCT01337570 Jul 2011 → Jul 2014 HIV infectious disease International Partnership for Microbicides, Inc. Withdrawn No outcome recorded
Phase not applicable1 trial
NCT01539226 Mar 2012 → Dec 2016 HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Also used as a comparator or background therapy in 7 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 15 trials
Phase 1 NCT05416021 Comparator Aug 2022 → Apr 2024 HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1 NCT03044379 Comparator Sep 2015 → Sep 2017 HIV infectious disease International Partnership for Microbicides, Inc. Withdrawn No outcome recorded
Phase 1 NCT02847286 Comparator Sep 2015 → Nov 2016 International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1 NCT02858024 Comparator Jan 2015 → Apr 2016 HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1 NCT01277640 Comparator Mar → Jul 2011 International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT00799058 Comparator Jul 2009 → Jan 2011 HIV infectious disease International Partnership for Microbicides, Inc. Completed No outcome recorded
Phase 41 trial
Phase 4 NCT07076043 Comparator Jun 2025 → Dec 2028 expected HIV infectious disease University of Alabama at Birmingham Recruiting No outcome recorded

Evidence & citations 14 cited values

Every value below carries the sentence it was read from. 49 sources stand behind the page.

FieldValueCited text
Known as dapivirine “We evaluated the acceptability of the 90-day dapivirine levonorgestrel ring (DPV-LNG ring) used for 14 days compared to a dapivirine-only ring (DVR-200mg) in MTN-030/IPM 041 (n...” PMID 39808648 Jan 2025
43

“containing the active ingredients dapivirine (DPV) and levonorgestrel (LNG), formulated as IPM VR: 200 mg DPV + 320 mg LNG (Ring-102)” NCT03467347

“To start, the dapivirine vaginal ring will be included among the other forms of PrEP that are available.” NCT07076043

“They then underwent 7-day exposure to a ring containing 120 mg of TMC120 (dapivirine).” NCT00700284

“DPV-LNG Ring containing xx mg of dapivirine + xx mg of levonorgestrel” NCT05041699

NCT00303576

NCT02847286

NCT02858037

NCT01952561

NCT02010593

NCT03044379

NCT02858024

NCT01731574

NCT03239483

NCT03074786

NCT01548560

NCT01617096

NCT00304642

NCT01363037

NCT00613249

NCT04140266

NCT01337583

NCT03965923

NCT00799058

NCT00332995

NCT03393468

NCT00469768

NCT06250504

NCT01242579

NCT02920827

NCT05416021

NCT00917904

NCT00917891

NCT00309205

NCT01144676

NCT00304668

NCT02808949

NCT01924091

NCT01539226

NCT02028338

NCT02862171

NCT03234400

NCT01277640

NCT01337570

Known as [14C]DAPIVIRINE ChEMBL registry synonym — accepted as the source's own label CHEMBL70663
Known as AIDS-105293 ChEMBL registry synonym — accepted as the source's own label CHEMBL70663
Known as DAPIRING DAPIRING (Dapivirine) 25mg Vaginal Ring” NCT06250504
Known as Dapivirina ChEMBL registry synonym — accepted as the source's own label CHEMBL70663
Known as dapivirine gel 4759 dapivirine gel 4759, 0.05%, 2.5g applied once daily” NCT00799058
Known as Dapivirine Gel 4789 “A Double-blind, Randomized, Placebo-Controlled Phase I/II Study to Evaluate the Safety and Acceptability of Dapivirine Gel 4789, 0.05%, 2.5g, a Vaginal Microbicide, Conducted...” NCT00917904
1

dapivirine gel 4789, 0.05%, 2.5g applied once daily” NCT00799058

Known as DPV “We evaluated the safety, pharmacokinetics, and acceptability of a microbicide dapivirine (DPV) vaginal ring (VR) versus placebo in postmenopausal women.” PMID 30289485 Mar 2019
6

“This study will evaluate the safety and drug detection of the dapivirine (DPV) vaginal ring (VR) and oral Truvada in breastfeeding mother-infant pairs.” NCT04140266

“Prior trials of a 25 mg dapivirine (DPV) ring have shown a favourable safety profile and approximately 30% risk reduction of HIV-1 infection.” PMID 34118115 Jun 2021

“containing the active ingredients dapivirine (DPV) and levonorgestrel (LNG), formulated as IPM VR: 200 mg DPV + 320 mg LNG (Ring-102)” NCT03467347

“Dapivirine (DPV), formulated as vaginal ring, demonstrated HIV risk reduction.” PMID 34498980 Dec 2021

“Dapivirine (DPV) is a nonnucleoside reverse transcriptase inhibitor” PMID 24070431 Oct 2013

“Dapivirine (DPV) Vaginal Ring (VR)” NCT03965923

Known as Gel-02 ChEMBL registry synonym — accepted as the source's own label CHEMBL70663
Known as R-147681 ChEMBL registry synonym — accepted as the source's own label CHEMBL70663
Known as TMC120 “candidate microbicide dapivirine (TMC120) for 7 days” NCT00332995
5

“pharmacokinetics of dapivirine (TMC120) gel” NCT00304642

“dapivirine (TMC120) vaginal gel” NCT00309205

“dapivirine (TMC120) vaginal gel” NCT00304668

“dapivirine (TMC120) vaginal gel” NCT00303576

NCT00700284

Action Inhibit “Dapivirine (DPV) is a nonnucleoside reverse transcriptase inhibitor” PMID 24070431 Oct 2013
Modality Small molecule “Dapivirine (DPV) is a nonnucleoside reverse transcriptase inhibitor” PMID 24070431 Oct 2013
Route Other “intravaginal gel, dosed daily” NCT00613249